S.298: Pharmacy Benefit Manager Accountability Study Act of 2021

About This Bill

Bill Cosponsor

Bill Version

Bill Summary

Pharmacy Benefit Manager Accountability Study Act of 2021 This bill requires the Government Accountability Office to report on the role of pharmacy benefit managers in the pharmaceutical supply chain and recommend legislative actions to lower the cost of prescription drugs. The report must address the use of rebates and fees, the average prior authorization approval time, and the use of step therapy within the 10 largest pharmacy benefit...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There are 3 statements associated with S.298.

Bill Actions

Date Description
Feb. 8, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Feb. 8, 2021

Introduced in the Senate by Marsha Blackburn (R-Tenn.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page